Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4b1f | KRH | Glutamate racemase |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4b1f | KRH | Glutamate racemase | / | 1.000 | |
| 2jfz | 003 | Glutamate racemase | / | 0.581 | |
| 3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.493 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.482 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.473 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.467 | |
| 2d29 | FAD | Acyl-CoA dehydrogenase | / | 0.465 | |
| 2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.460 | |
| 1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.458 | |
| 3ibd | CPZ | Cytochrome P450 2B6 | 1.14.13 | 0.457 | |
| 3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.455 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.452 | |
| 4nie | NBH | Nuclear receptor ROR-gamma | / | 0.451 | |
| 1m13 | HYF | Nuclear receptor subfamily 1 group I member 2 | / | 0.450 | |
| 1s0x | C3S | Nuclear receptor ROR-alpha | / | 0.450 | |
| 4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.450 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.447 | |
| 1fwm | CB3 | Thymidylate synthase | / | 0.446 | |
| 3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.446 | |
| 4o7u | THF | Thymidylate synthase | / | 0.446 | |
| 4ryv | ZEA | Protein LlR18A | / | 0.446 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 2w4q | CBW | Prostaglandin reductase 2 | 1.3.1.48 | 0.445 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.445 | |
| 1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.444 | |
| 3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.444 | |
| 3lu8 | IQX | Serum albumin | / | 0.444 | |
| 5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.444 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.443 | |
| 1ci7 | CB3 | Thymidylate synthase | 2.1.1.45 | 0.442 | |
| 3vtb | TKA | Vitamin D3 receptor | / | 0.442 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.441 | |
| 4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2fr0 | NDP | 6-deoxyerythronolide-B synthase EryA1, modules 1 and 2 | / | 0.440 | |
| 3w0j | T08 | Vitamin D3 receptor | / | 0.440 |